Marty Makary praises Trump’s FDA actions to address excessive pharmaceutical advertisements with ‘Pod Force One’
FDA Takes Action on Drug Advertising President Trump’s administration is stepping up efforts to regulate the overwhelming number of drug advertisements that Americans encounter daily, according to FDA Commissioner Marty McCulley during a recent appearance on “Pod Force One.” “It’s really becoming a problem,” McCulley shared with host Miranda Devine. “The relationship between doctors and […]
Republicans Urge FDA to Overturn Biden’s ‘Mail-Order Abortion Plan’
Representatives Chris Smith (R-N.J.) and Diana Hershberger (R-Tenn.) have spearheaded a letter with the support of 175 House Republicans. They are calling on the Food and Drug Administration (FDA) and the Department of Health and Human Services (HHS) to retract the Biden administration’s “mail-order abortion plan” and to examine potential safety concerns regarding abortion pills. […]
Missouri files a lawsuit against the FDA regarding the approval of generic mifepristone, citing safety concerns.
Missouri Attorney General Expands Legal Action Against Mail-Order Abortion Pills On Thursday, Missouri Attorney General Katherine Hannaway announced an expansion of the state’s legal efforts against mail-order abortion pills, specifically targeting the new generic version of mifepristone. Hannaway argues that these medications are leading to serious hospitalizations due to “life-threatening complications” and are entering the […]
FDA takes steps to remove ‘black box’ warnings on hormone therapy for menopause
FDA to Remove Warnings from Hormone Replacement Therapy Products The U.S. Food and Drug Administration (FDA) has announced plans to eliminate “black box” warning labels from hormone replacement therapy (HRT) products aimed at easing menopause symptoms. Dr. Marty McCurry, the FDA Commissioner, stated that this decision is backed by years of research and clinical trials […]
FDA lifting warnings on hormone replacement therapy products
Removal of Warnings on HRT Products Announced The Secretary of Health and Human Services, Robert F. Kennedy Jr., declared on Monday that the black box warnings associated with estrogen-based hormone replacement therapy (HRT) for women will be eliminated. “For over two decades, American medical institutions have turned their backs on women,” Kennedy stated during a […]
FDA alerts that widely used skin treatment may lead to severe complications
The FDA’s Warning on RF Microneedling The FDA has raised concerns about a popular skin treatment known for its celebrity following. While it’s been marketed to tackle issues like wrinkles, pigmentation, and acne scars, there have been some alarming reports regarding its safety. Radiofrequency (RF) microneedling involves using tiny electrodes to resurface the skin, reminiscent […]
FDA eases regulations on biosimilars to save billions on medications
Rising Costs in Prescription Drugs and the Role of Biosimilars The most rapidly growing area of health care spending is on prescription medications. At the forefront are biologics, which can cost up to $200,000 annually. There are “generic” alternatives known as biosimilars that have the potential to save Americans billions, yet their adoption is stymied […]
FDA takes action against fluoride supplements for kids
FDA Issues Warnings on Fluoride Medications for Children The Food and Drug Administration (FDA) has issued warnings to four companies concerning their sale of “unapproved fluoride-containing oral medications” intended for children under three, as well as for those at low or moderate risk of tooth decay. “This Halloween, the FDA is putting an end to […]
Senators Hawley and Cassidy raise concerns about FDA collaborations regarding medication for abortion.
Republican Senators Question FDA on Abortion Pill Safety On Wednesday, several Republican senators criticized the Food and Drug Administration (FDA) for allegedly broadening access to abortion pills without adequate oversight. They urged the agency to reinforce safety regulations and reassess its partnerships concerning these medications. During a conference call, Senators Josh Hawley from Missouri and […]
FDA Urges More Affordable Generic Versions of Expensive Drugs
New Push for Affordable Health Care Drugs President Trump’s health advisors announced an initiative to reduce health care costs by increasing the availability of innovative generic drugs during a press conference on Wednesday. The Food and Drug Administration (FDA) revealed plans to clear bureaucratic obstacles that currently protect its monopoly on biologics, many of which […]